The 2026 ICD-10-CM code N63.11 denotes a clinical finding of an unspecified mass, lump, or nodule located in the upper outer quadrant (UOQ) of the right breast. The upper outer quadrant, which extends toward the axilla (containing the axillary tail of Spence), has the highest concentration of glandular tissue and is the most common site for both benign and malignant breast lesions. The term 'unspecified' indicates that while a palpable mass or radiographic abnormality has been identified, its definitive pathological nature—such as a simple cyst, fibroadenoma, or primary malignancy—has not yet been established. Clinical management for this finding typically follows the 'triple assessment' protocol: physical examination, diagnostic imaging (mammography and/or ultrasound), and potentially a core needle biopsy if the BI-RADS assessment warrants tissue sampling. This code is essential for documenting physical findings in the early diagnostic phase and for tracking medical necessity for further diagnostic workup.
Specify the exact clock position and distance from the nipple in addition to the quadrant.
Example: Patient presents with a 2 cm firm, mobile, non-tender lump located at the 10 o clock position in the right breast, upper outer quadrant, approximately 4 cm from the nipple. This finding is documented to support N63.11 and justify CPT 76641. Current assessment is a palpable mass requiring diagnostic workup to rule out malignancy, which impacts HCC risk adjustment if confirmed as neoplastic.
Billing Focus: Documentation must specify the right breast and the upper outer quadrant to support the 4th and 5th characters of the ICD-10 code.
Document the presence or absence of associated skin changes or nipple retraction.
Example: Clinical exam of the right breast upper outer quadrant reveals an unspecified lump without associated skin dimpling, peau d orange, or nipple retraction. No axillary lymphadenopathy noted on the right side. These negative findings are critical for differentiating between N63.11 and potentially malignant conditions under C50.411, impacting both billing specificity and severity staging.
Billing Focus: Clear documentation of associated symptoms or their absence supports the medical necessity of diagnostic imaging like 77066.
Correlate palpable findings with previous imaging or biopsy results if available.
Example: Palpable 1.5 cm mass in the right breast upper outer quadrant corresponds to the area of architectural distortion noted on the previous screening mammogram. Patient has a family history of breast cancer in a first-degree relative. The diagnosis of N63.11 is used pending biopsy results. The complexity of this case is moderate due to the need to correlate clinical findings with historical data and family risk factors.
Billing Focus: Linking the lump to previous imaging findings supports the transition from screening to diagnostic status for CPT 77066.
Identify if the lump is fixed to the chest wall or skin.
Example: Examination of the right breast upper outer quadrant shows a firm lump that is mobile and not fixed to the pectoralis fascia or the overlying dermis. No pain or discharge. Given the persistence of this unspecified lump (N63.11), a core needle biopsy (CPT 19081) is scheduled. Detailed documentation of mobility assists in determining the procedural approach and surgical planning if excision is required.
Billing Focus: Mobility vs. fixation supports the level of surgical complexity and helps justify the use of specific CPT surgical codes.
State the duration and any changes in the lump relative to the menstrual cycle.
Example: The patient reports an unspecified lump in the right breast upper outer quadrant that has been present for three months and does not fluctuate in size with her menstrual cycle. On exam, a discrete mass is palpable. Diagnosis N63.11 is assigned. The lack of cyclical change increases the suspicion for a non-functional lesion and supports the medical necessity for ultrasound CPT 76641.
Billing Focus: Duration and stability documentation supports the medical necessity of the visit and subsequent diagnostic procedures.
Standard for a new patient presenting with a newly discovered breast lump requiring a low level of complexity to evaluate and order initial imaging.
Used for established patients presenting with a lump or for follow-up of initial imaging results that remain inconclusive.
Primary diagnostic tool to characterize a palpable mass in the right breast upper outer quadrant as cystic or solid.
Necessary for evaluating the upper outer quadrant in the right breast when a lump is detected.
Used if the unspecified lump (N63.11) appears suspicious on mammography and requires tissue sampling.
The definitive treatment for an unspecified lump that is symptomatic, enlarging, or suspicious for malignancy.
Often performed when a lump is suspected to be a simple cyst based on palpation or ultrasound.
Used if the lump in the upper outer quadrant is associated with localized nipple discharge.
Used for quick bedside assessment of palpable masses in the upper outer quadrant.
Applied when the patient has comorbidities or the lump workup requires complex coordination or discussion of biopsy results.